Lionsgate Studios director receives share and RSU grants at $7.46

Lionsgate Studios Corp. reported a new equity grant to a director.

Rhea-AI Filing Summary

Lionsgate Studios Corp. reported a new equity grant to a director. On 11/28/2025, the director acquired 6,702 common shares at $7.46 per share as part of director fees, bringing direct beneficial ownership to 131,536 common shares. On the same date, the director also received 20,107 restricted share units valued at $7.46 per share, each payable in one common share upon vesting.

The restricted share units are scheduled to vest in one remaining equal annual installment on November 28, 2026, which would then be delivered in common shares. The filing is made by a single reporting person in the capacity of director of Lionsgate Studios Corp.

Insider Trade Summary

Grant/Award: 26,809 shares

Grant/Award 2 txns

Insider FINE EMILY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,702	$7.46	$50K
Grant/Award	Common Shares	20,107	$7.46	$150K

Holdings After Transaction: Common Shares — 20,107 shares (Direct)

Footnotes (2)

1. F1. Director fees granted in Common Shares of the Issuer.
2. F2. These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one remaining equal annual installment on November 28, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Lionsgate Studios Corp. (LION) report in this Form 4?

Lionsgate Studios Corp. reported that a director acquired 6,702 common shares on 11/28/2025 at a price of $7.46 per share as part of director compensation.

How many Lionsgate Studios Corp. (LION) shares does the director own after the transaction?

Following the transaction, the director beneficially owns 131,536 common shares directly, as disclosed in the filing.

Were restricted share units granted in this Lionsgate Studios Corp. (LION) filing?

Yes. The director received 20,107 restricted share units, each payable in one common share of Lionsgate Studios Corp., referenced at $7.46 per share.

When do the restricted share units for Lionsgate Studios Corp. (LION) vest?

The restricted share units are scheduled to vest in one remaining equal annual installment on November 28, 2026.

What is the reporting person’s relationship to Lionsgate Studios Corp. (LION)?

The reporting person is a director of Lionsgate Studios Corp., as indicated in the relationship section of the filing.

Is this Lionsgate Studios Corp. (LION) Form 4 filed by one or multiple insiders?

The document states that the Form 4 is filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/02/2025 - 05:05 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FINE EMILY

(Last) (First) (Middle)

40 WEST 57TH STREET

FLOOR 24

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/28/2025		A		6,702(1)	A	$7.46	131,536	D
Common Shares	11/28/2025		A		20,107	A	$7.46	20,107(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Director fees granted in Common Shares of the Issuer.

2. These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one remaining equal annual installment on November 28, 2026.

	/s/ Emily Fine	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.